Chaperone-rich tumor cell lysate-mediated activation of antigen-presenting cells resists regulatory T cell suppression

Nicolas Larmonier, Jessica Cantrell, Collin LaCasse, Gang Li, Nona Janikashvili, Elaine Situ, Marjan Sepassi, Samita Andreansky, Emmanuel Katsanis

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

CD4+CD25+ regulatory T lymphocytes (Tregs) critically contribute to the mechanisms of cancer-induced tolerance. These cells suppress anti-tumoral CD8+ and CD4+ T lymphocytes and can also restrain the function of APCs. We have previously documented the immunostimulatory effects of a chaperone-rich cell lysate (CRCL) anti-cancer vaccine. Tumor-derived CRCL induces tumor immunity in vivo, partly by promoting dendritic cell (DC) and macrophage activation. In the current study, we evaluated the effects of CD4+CD25+forkhead box P3 + Tregs isolated from mice bearing 12B1 bcr-abl+ leukemia on DC and macrophages that had been activated by 12B1-derived CRCL. CRCL-activated DC and macrophages resisted Treg suppression, as the production of proinflammatory cytokines, the activation of transcription factor NF-κB, and their immunostimulatory potential was unaffected by Tregs. Our results thus highlight CRCL as a powerful adjuvant endowed with the capacity to overcome tumor-induced Treg-inhibitory effects on APCs.

Original languageEnglish
Pages (from-to)1049-1059
Number of pages11
JournalJournal of Leukocyte Biology
Volume83
Issue number4
DOIs
StatePublished - Apr 1 2008
Externally publishedYes

Fingerprint

Antigen-Presenting Cells
Regulatory T-Lymphocytes
Dendritic Cells
Neoplasms
Macrophages
Cancer Vaccines
Macrophage Activation
Immunity
Leukemia
Transcription Factors
Cytokines
T-Lymphocytes

Keywords

  • CD4CD25 regulatory T lymphocytes
  • Chaperone-rich cell lysate
  • Dendritic cells
  • Monocytes-macrophages

ASJC Scopus subject areas

  • Cell Biology

Cite this

Larmonier, N., Cantrell, J., LaCasse, C., Li, G., Janikashvili, N., Situ, E., ... Katsanis, E. (2008). Chaperone-rich tumor cell lysate-mediated activation of antigen-presenting cells resists regulatory T cell suppression. Journal of Leukocyte Biology, 83(4), 1049-1059. https://doi.org/10.1189/jlb.0907635

Chaperone-rich tumor cell lysate-mediated activation of antigen-presenting cells resists regulatory T cell suppression. / Larmonier, Nicolas; Cantrell, Jessica; LaCasse, Collin; Li, Gang; Janikashvili, Nona; Situ, Elaine; Sepassi, Marjan; Andreansky, Samita; Katsanis, Emmanuel.

In: Journal of Leukocyte Biology, Vol. 83, No. 4, 01.04.2008, p. 1049-1059.

Research output: Contribution to journalArticle

Larmonier, N, Cantrell, J, LaCasse, C, Li, G, Janikashvili, N, Situ, E, Sepassi, M, Andreansky, S & Katsanis, E 2008, 'Chaperone-rich tumor cell lysate-mediated activation of antigen-presenting cells resists regulatory T cell suppression', Journal of Leukocyte Biology, vol. 83, no. 4, pp. 1049-1059. https://doi.org/10.1189/jlb.0907635
Larmonier, Nicolas ; Cantrell, Jessica ; LaCasse, Collin ; Li, Gang ; Janikashvili, Nona ; Situ, Elaine ; Sepassi, Marjan ; Andreansky, Samita ; Katsanis, Emmanuel. / Chaperone-rich tumor cell lysate-mediated activation of antigen-presenting cells resists regulatory T cell suppression. In: Journal of Leukocyte Biology. 2008 ; Vol. 83, No. 4. pp. 1049-1059.
@article{0646850544cf42179d66362cefd591e7,
title = "Chaperone-rich tumor cell lysate-mediated activation of antigen-presenting cells resists regulatory T cell suppression",
abstract = "CD4+CD25+ regulatory T lymphocytes (Tregs) critically contribute to the mechanisms of cancer-induced tolerance. These cells suppress anti-tumoral CD8+ and CD4+ T lymphocytes and can also restrain the function of APCs. We have previously documented the immunostimulatory effects of a chaperone-rich cell lysate (CRCL) anti-cancer vaccine. Tumor-derived CRCL induces tumor immunity in vivo, partly by promoting dendritic cell (DC) and macrophage activation. In the current study, we evaluated the effects of CD4+CD25+forkhead box P3 + Tregs isolated from mice bearing 12B1 bcr-abl+ leukemia on DC and macrophages that had been activated by 12B1-derived CRCL. CRCL-activated DC and macrophages resisted Treg suppression, as the production of proinflammatory cytokines, the activation of transcription factor NF-κB, and their immunostimulatory potential was unaffected by Tregs. Our results thus highlight CRCL as a powerful adjuvant endowed with the capacity to overcome tumor-induced Treg-inhibitory effects on APCs.",
keywords = "CD4CD25 regulatory T lymphocytes, Chaperone-rich cell lysate, Dendritic cells, Monocytes-macrophages",
author = "Nicolas Larmonier and Jessica Cantrell and Collin LaCasse and Gang Li and Nona Janikashvili and Elaine Situ and Marjan Sepassi and Samita Andreansky and Emmanuel Katsanis",
year = "2008",
month = "4",
day = "1",
doi = "10.1189/jlb.0907635",
language = "English",
volume = "83",
pages = "1049--1059",
journal = "Journal of Leukocyte Biology",
issn = "0741-5400",
publisher = "FASEB",
number = "4",

}

TY - JOUR

T1 - Chaperone-rich tumor cell lysate-mediated activation of antigen-presenting cells resists regulatory T cell suppression

AU - Larmonier, Nicolas

AU - Cantrell, Jessica

AU - LaCasse, Collin

AU - Li, Gang

AU - Janikashvili, Nona

AU - Situ, Elaine

AU - Sepassi, Marjan

AU - Andreansky, Samita

AU - Katsanis, Emmanuel

PY - 2008/4/1

Y1 - 2008/4/1

N2 - CD4+CD25+ regulatory T lymphocytes (Tregs) critically contribute to the mechanisms of cancer-induced tolerance. These cells suppress anti-tumoral CD8+ and CD4+ T lymphocytes and can also restrain the function of APCs. We have previously documented the immunostimulatory effects of a chaperone-rich cell lysate (CRCL) anti-cancer vaccine. Tumor-derived CRCL induces tumor immunity in vivo, partly by promoting dendritic cell (DC) and macrophage activation. In the current study, we evaluated the effects of CD4+CD25+forkhead box P3 + Tregs isolated from mice bearing 12B1 bcr-abl+ leukemia on DC and macrophages that had been activated by 12B1-derived CRCL. CRCL-activated DC and macrophages resisted Treg suppression, as the production of proinflammatory cytokines, the activation of transcription factor NF-κB, and their immunostimulatory potential was unaffected by Tregs. Our results thus highlight CRCL as a powerful adjuvant endowed with the capacity to overcome tumor-induced Treg-inhibitory effects on APCs.

AB - CD4+CD25+ regulatory T lymphocytes (Tregs) critically contribute to the mechanisms of cancer-induced tolerance. These cells suppress anti-tumoral CD8+ and CD4+ T lymphocytes and can also restrain the function of APCs. We have previously documented the immunostimulatory effects of a chaperone-rich cell lysate (CRCL) anti-cancer vaccine. Tumor-derived CRCL induces tumor immunity in vivo, partly by promoting dendritic cell (DC) and macrophage activation. In the current study, we evaluated the effects of CD4+CD25+forkhead box P3 + Tregs isolated from mice bearing 12B1 bcr-abl+ leukemia on DC and macrophages that had been activated by 12B1-derived CRCL. CRCL-activated DC and macrophages resisted Treg suppression, as the production of proinflammatory cytokines, the activation of transcription factor NF-κB, and their immunostimulatory potential was unaffected by Tregs. Our results thus highlight CRCL as a powerful adjuvant endowed with the capacity to overcome tumor-induced Treg-inhibitory effects on APCs.

KW - CD4CD25 regulatory T lymphocytes

KW - Chaperone-rich cell lysate

KW - Dendritic cells

KW - Monocytes-macrophages

UR - http://www.scopus.com/inward/record.url?scp=44449112373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44449112373&partnerID=8YFLogxK

U2 - 10.1189/jlb.0907635

DO - 10.1189/jlb.0907635

M3 - Article

C2 - 18174364

AN - SCOPUS:44449112373

VL - 83

SP - 1049

EP - 1059

JO - Journal of Leukocyte Biology

JF - Journal of Leukocyte Biology

SN - 0741-5400

IS - 4

ER -